88040994791Infect Control Hosp EpidemiolInfect Control Hosp EpidemiolInfection control and hospital epidemiology0899-823X1559-683424602955418336010.1086/675610NIHMS581209ArticlePoint Prevalence of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae in MarylandJohnsonJ. KristiePh.D12WilsonLucy E.MD, ScM3ZhaoLiChengPh.D1RichardsKatherineMPH3ThomKerri A.MD2HarrisAnthony D.MD2the Maryland MDRO Prevention CollaborativeDepartments of Pathology, University of Maryland School of Medicine Baltimore, Maryland Epidemiology and Public Health, University of Maryland School of Medicine Baltimore, Maryland Maryland Department of Health and Mental Hygiene, Baltimore, Maryland Corresponding Author: J. Kristie Johnson, Ph.D. Associate Professor, Departments of Pathology and Epidemiology and Public Health University of Maryland School of Medicine 22 South Greene Street, Room N2W69 Baltimore, Maryland 21201 jkjohnson@som.umaryland.edu652014420140142015354443445

Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as significant healthcare-associated multidrug-resistant pathogens across the United States.1 Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae (KPCs) are the primary organisms of antibiotic resistance for this type of infection in the US.2 Bacterial strains that harbor carbapenem resistance genes have shown resistance to all known first line therapeutic options and the threat of the spread of these organisms is of great concern to the US healthcare system.3 Colonization and infection with KPCs have been associated with several healthcare-associated factors, and an increase in associated morbidity and mortality has been documented.4

Despite its notoriety, the true burden of KPCs is unknown. The colonized patient is an important reservoir of CREs and represents a key to understanding the spread and control of these organisms. In this study, we determined the colonization prevalence of KPCs in a cohort of mechanically ventilated patients residing in all healthcare settings (acute and long term care) by performing a statewide prospective cross-sectional prevalence survey to determine the burden of KPCs in Maryland.

All healthcare facilities that provide care to mechanically ventilated patients in Maryland were invited to participate; participation was voluntary. The prevalence survey was performed during a 12-day period from July-August 2010. Each facility collected peri-anal and sputum samples from eligible patients. The survey was performed as a public health initiative and no patient identifying information was collected. Peri-anal cultures were obtained using Staplex II cotton swabs (Staplex) and sputum cultures were collected during routine respiratory care. All samples were analyzed for a previous study and frozen at −70°C.5 The samples were thawed and the detection of KPCs was performed following the CDC method.6 Susceptibility testing and amplification and sequencing of blaKPC was performed on all isolates.7,8 Multi-locus sequence typing was performed on KPC-producing Klebsiella pneumoniae and Escherichia coli isolates to determine strain relatedness.

Forty (70%) of the 57 eligible healthcare facilities within 5 regions of Maryland participated in the survey (Figure 1); 30 (67%) of the eligible acute care facilities and 10 (83%) of the eligible LTC facilities. Among the 40 facilities that participated, five facilities (four acute care and one LTC) did not have an eligible/ventilated patient during the study period and therefore no specimens were collected. Characteristics of participating facilities were published previously.5

Among participating facilities, there were 390 patients eligible to be enrolled and surveillance cultures were obtained from 358 (92%). KPC-producing genes were detected in 22 bacterial isolates from 20 (6%) patients (5 sputa and 17 peri-anal; Table 1). Two patients had KPCs detected in both the sputum and peri-anal specimen. KPCs were isolated from patients in 9 (23%) healthcare facilities, 4 acute care and 5 LTC facilities. Eleven (55%) of the 20 patients resided in a LTC facility. KPCs were found in two regions of Maryland. Culture detected 15 K. pneumoniae, 6 E. coli, and 1 Enterobacter cloacae. Of these isolates, 19 harbored the blaKPC-2 and 3 harbored the blaKPC-3. Molecular typing revealed three different K. pneumoniae strains found in 4 acute care and 3 LTC facilities. Of the K. pneumoniae isolates, 60% (9/15) were ST 258 found in 6 healthcare facilities (3 acute care and 3 LTC). There were four different E. coli strains detected in 4 facilities (1 acute care and 3 LTC). Of the E. coli 50% (3/6) were ST 131 found in 1 acute care and 2 LTC facilities. One facility had KPC producing K. pneumoniae, E. coli, and E. cloacae detected harboring either the KPC-2 or KPC-3 gene.

We found that mechanically ventilated patients have a high prevalence of KPCs within a variety of healthcare facilities in Maryland. We showed that 6% of patients from 40 acute care and LTC facilities in Maryland were colonized with KPC-producing Enterobacteriaceae. 55% of the KPCs were found in LTC facilities. KPCs were found primarily in peri-anal swabs but in three patients, KPCs were only found in the sputum. These CREs were detected exclusively in the central and national capital regions in Maryland, which are more populated areas with a higher number of healthcare facilities. Molecular typing data showed transmission of organisms within and between healthcare facilities.

KPCs are emerging as a serious threat within the US, yet the true burden is unknown. In 2012, the CDC reported that 4.6% of acute care hospitals reported at least one CRE from clinical cultures.9 However, previous to this study, no statewide active surveillance of the true burden of CREs has been reported anywhere in the nation. Thibodeau et al performed a voluntary, statewide, paper-based survey on clinical cultures in Massachusetts hospitals and found that nearly half of all Massachusetts hospitals detected a CRE in 2010 and that these CREs were more often detected in teaching hospitals than non-teaching hospitals.10 However, the use of clinical cultures only as well as the use of differing definitions of CREs make it difficult to interpret the Massachusetts results. In our study we collected surveillance peri-anal and sputum cultures and used enrichment techniques to determine the prevalence of KPCs utilizing identical laboratory methods and definitions for each facility. We also performed molecular typing on bacterial strains harboring KPCs and revealed a dominant strain type for both K. pneumoniae and E. coli.

This study has several limitations. We could not rule out response bias since only 70% of the healthcare facilities participated in survey. At the time of this study, the importance of urine as a specimen to detect CREs was unknown therefore we might have missed patients colonized with KPCs. In addition, this point prevalence was limited to patients receiving mechanical ventilation, who are known to have higher rates of colonization, and therefore the KPC prevalence cannot be generalized to other patients populations.

In conclusion, this is the first study to our knowledge to examine the colonization rate of KPCs in a cohort of mechanically ventilated patients residing in both acute and long term care healthcare facilities in one state within the United States.

Acknowledgements

Financial support: This work was supported by the Centers for Disease Control and Prevention, American Recovery and Reinvestment Act Epidemiology and Laboratory Capacity for Infectious Diseases (ELC), Healthcare-Associated Infections–Building and Sustaining State Programs to Prevent Healthcare-Associated Infections funding opportunity CI07-70402ARRA09. J.K.J is funded by the National Institutes of health (K12RR023250). K.A.T. is supported by the National Institutes of Health (K23AI082450-01A1). A.D.H. is supported by the National Institutes of Health (K24AI079040, R01AI60859-01A1, and 2R01AI060859)

Potential Conflicts of Interest: All authors: No reported conflicts.

Part of this work has been presented previously at the 52th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, September 2012.

LandmanDBabuEShahNTransmission of carbapenem-resistant pathogens in new york city hospitals: Progress and frustrationJ Antimicrob Chemother201267614271431doi: 10.1093/jac/dks06322378678GuptaNLimabagoBPatelJKallenACarbapenem-Resistant Enterobacteriaceae: Epidemiology and PreventionClinical Infectious Disease20115316067QueenanABKarenCarbapenemases: The versatile beta-lactamasesClin Microbiol Rev200720344058table of contents. doi: 10.1128/CMR.00001-0717630334PatelGHuprikarSFactorSJenkinsSCalfeeDOutcomes of carbapenem-resistant klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapiesInfection control and hospital epidemiology2008291210991106doi: 10.1086/59241218973455ThomKerri MaragakisRichardsLisaJohnsonKatieRoupJKLawsonBrendaHarrisPatriciaFussAnthonyPassElizabethBlytheMargaretPerencevichDavidEli WilsonLucyAssessing the burden of acinetobacter baumannii in maryland: A statewide cross-sectional period prevalence surveyInfection control and hospital epidemiology2012339883888doi: 10.1086/66737622869261CalfeeDJStephenUse of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant klebsiella pneumoniae in intensive care unit patientsInfection control and hospital epidemiology20082910966968doi: 10.1086/59066118754738Clinical and Laboratory Standards InstitutePerformance standards for antimicrobial disk susceptibility testing; twenty -second informational supplement2012RasheedBiddleJKAndersonJamesWasherKarenChenowethLarainePerrinCarolNewtonJohnPatelDuaneJeanDetection of the klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of citrobacter freundii and K. oxytoca carrying a common plasmidJ Clin Microbiol200846620662069doi: 10.1128/JCM.02038-0718385437Vital signs: Carbapenem-resistant enterobacteriaceaeMorb Mortal Weekly Rep2013629165170ThibodeauDuncanEvangelineSnydmanRobertBolstorffDavidVostokBarbaraBartonJohannaDemariaKerriAlfredCarbapenem-resistant enterobacteriaceae: A statewide survey of detection in massachusetts hospitalsInfection control and hospital epidemiology2012339954956doi: 10.1086/66737722869273

Seventy (70%) of Maryland Healthcare centers with mechanically ventilated patients participated in the study. KPC-producing Enterobacteriaceae were found in 23% of facilities, which were located in 2 major regions of Maryland.

Characterization of Enterobacteriaceae-producing Klebsiella pneumoniae carbapeneamase.

PatientFacilityFacilityTypeRegionSpecimenOrganismSequenceTypeblaKPC
11LTCCentral Marylandsputum K. pneumoniae 15KPC-3
21LTCCentral Marylandperi-anal E. coli 167KPC-2
32LTCCentral Marylandperi-anal K. pneumoniae 258KPC-2
43AcuteCentral Marylandsputum K. pneumoniae 258KPC-2
53AcuteCentral Marylandperi-anal E. coli 95KPC-3
63AcuteCentral Marylandperi-anal E. coli 131KPC-2
73AcuteCentral Marylandperi-anal E. cloacae NT*KPC-2
84LTCCentral Marylandperi-anal K. pneumoniae 258KPC-2
94LTCCentral Marylandperi-anal E. coli 131KPC-2
104LTCCentral Marylandperi-anal E. coli 167KPC-2
115LTCCentral Marylandperi-anal E. coli 131KPC-2
126AcuteNational Capitalperi-anal K. pneumoniae 258KPC-2
137AcuteCentral Marylandperi-anal K. pneumoniae 15KPC-3
14-18LTCNational Capitalperi-anal K. pneumoniae 258KPC-2
14-28LTCNational Capitalsputum K. pneumoniae 258KPC-2
158LTCNational Capitalperi-anal K. pneumoniae 340KPC-2
168LTCNational Capitalperi-anal K. pneumoniae 340KPC-2
178LTCNational Capitalperi-anal K. pneumoniae 258KPC-2
189AcuteNational Capitalperi-anal K. pneumoniae 258KPC-2
19-19AcuteNational Capitalperi-anal K. pneumoniae 258KPC-2
19-29AcuteNational Capitalsputum K. pneumoniae 258KPC-2
209AcuteNational Capitalsputum K. pneumoniae 258KPC-2

NT: not tested